跳至主要内容
临床试验/ISRCTN10709813
ISRCTN10709813已完成未知

Assessment of remote heart rhythm sampling using AliveCor® to screen an at risk population of atrial fibrillation: a randomised controlled trial

ABMU Health Board0 个研究点目标入组 1,001 人开始时间: 2015年7月9日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,001

研究概览

简要总结

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28851729 results 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37205320/ (added 17/08/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female 65 years+ with one or more of the following risk factors, or 75 years+ with or without these risk factors;
  • 1.1. Hypertension currently treated
  • 1.2. Blood pressure >130/80mmHg not treated
  • 1.3. Any previous stroke or transient ischaemic attack (TIA)
  • 1.4. Diabetes (type 1 or type 2)
  • 1.5. Heart failure
  • 1.6. Ischaemic heart disease
  • 1.7. Peripheral artery disease
  • 2. Local access to the internet

排除标准

  • 1. Known atrial fibrillation
  • 2. Currently receiving anticoagulants
  • 3. Known contraindication to anticoagulation (chronic haematology conditions/previous haemorrhagic stroke/ongoing bleeding/liver disease)
  • 4. No access locally to internet
  • 5. Unable to operate the AliveCor® system

研究者

发起方
ABMU Health Board

相似试验